CORRECTING and REPLACING NanOlogy Publishes Review Article of Preclinical and Clinical Research Supporting LSAM-DTX
FORT WORTH, Texas–(BUSINESS WIRE)–In the second paragraph, first sentence of release dated September 20, 2022, the URL embedded under the phrase “review article” has been updated. The updated release reads: NANOLOGY PUBLISHES REVIEW ARTICLE OF PRECLINICAL AND CLINICAL RESEARCH SUPPORTING LSAM-DTX NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today that a review article … [Read more…]
